Ligand Pharmaceuticals | LGND - صافي الدخل





صافي الدخل تغيير تاريخ
Agenus USD -10.63M 74.49M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Enviri Corporation USD -84.28M 61.97M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
Merck USD 2.96B 2.82B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 41.15M 22.01M 2025-12